# The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024, Regulation 33: Amendment to regulation 50I

Extent: E+W+S+N.I.

In regulation 50I (applications relating to conditional marketing authorisations)—
(a) in the heading, omit “for sale or supply in Great Britain only”;
(b) in paragraph (1), for “a UKMA(GB)” substitute “a UKMA(UK)(Category 1)”.

---
Source: https://www.legislation.gov.uk/uksi/2024/832/regulation/33 (the official version)
Page: https://openlegislation.uk/human-medicines-amendments-relating-to-the-windsor-framework-regulations-2024/regulation-33
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.